Labopharm has reacquired the sales and marketing rights to its once-daily tramadol product for the UK from Recordati Ireland.
July 12, 2008
Labopharm reaquires UK rights to pain drug (Pharmaceutical Business Review)
John S. Brana - Distinctive Jewelry - Adds Rings and 14K Gold to the SoMa Hammered Metal Jewelry Collection (PRWeb via Yahoo! News)
John S. Brana - Distinctive Jewelry enhances popular SoMa Collection of hammered jewelry with rings and incorporates 14K gold.
Labopharm Submits Complete Response to FDA as a Result of Outcome of Appeal Process for Once-Daily Tramadol (CNW Group via Yahoo! Finance)
Labopharm Inc. today announced that it has submitted a complete response to the Food and Drug Administration per the suggestion of Dr. Douglas Throckmorton, M.D., the FDA’s Deputy Director, Center for Drug Evaluation and Research , as the next step in the regulatory path towards potential U.S. approval of the Company’s once-daily formulation of tramadol.
Update on Treatment of Low Back Pain: Part 2 (Psychiatric Times)
As noted in my last column (“Evaluation and Management of Low Back Pain: Part 1,” Psychiatric Times , May 2008, page 32), the American College of Physicians and the American Pain Society released the first comprehensive guideline on chronic low back pain (LBP) based on published evidence. 1-3 In the May column, I discussed the guideline recommendations for evaluating patients.